Author : Microbia, Inc. and Forest Laboratories, Inc. Earthtimes, UK - Mar 4, 2008 Preliminary analysis of the CC study data and an interim analysis of the IBS-C study data indicate that each study met its primary endpoint. ...
Salix Pharmaceuticals Reports 4Q2007 and FY2007 Results Business Wire (press release), CA - Mar 3, 2008 In 2011 and beyond, assuming the approval of rifaximin for IBS and hepatic encephalopathy, addressing a combined market of approximately $2.8 billion, ...
IBS eyes Indian aviation industry for growth Business Standard, India - Feb 20, 2008 Jet Airways has signed a seven-year contract to implement IBS’ crew management system — AvientCrew — to support the airlines' crew management needs. ...